 Saint- Herblain France, July 29 , 2021 Valneva SE Nasdaq: VALN; Euronext Paris: VLA, a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need, today announced the appointment of Peter Buhler as Chief Financial Officer CFO and Management Board member. 